Download Slide 1

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

NEDD9 wikipedia , lookup

Deoxyribozyme wikipedia , lookup

Therapeutic gene modulation wikipedia , lookup

United Kingdom National DNA Database wikipedia , lookup

Human genetic variation wikipedia , lookup

Extrachromosomal DNA wikipedia , lookup

Genomics wikipedia , lookup

Genetic testing wikipedia , lookup

Site-specific recombinase technology wikipedia , lookup

Cre-Lox recombination wikipedia , lookup

Non-coding DNA wikipedia , lookup

Cell-free fetal DNA wikipedia , lookup

Genome editing wikipedia , lookup

Mir-92 microRNA precursor family wikipedia , lookup

Artificial gene synthesis wikipedia , lookup

Genome (book) wikipedia , lookup

Medical genetics wikipedia , lookup

Public health genomics wikipedia , lookup

Designer baby wikipedia , lookup

Microevolution wikipedia , lookup

Genetic engineering wikipedia , lookup

Vectors in gene therapy wikipedia , lookup

History of genetic engineering wikipedia , lookup

Transcript
Genetic Repositories Australia
BACKGROUND
 GRA supported by an NHMRC Enabling Facility Grant awarded in 2006.
 Chief Investigators on the NHMRC Enabling Grant are –
Professor Peter Schofield (Prince of Wales Medical Research Institute &
University of New South Wales)
 Dr Juleen Cavanaugh (Australian National University, Medical School, Canberra
Hospital)
 Dr Susan Forrest (Australian Genome Research Facility)
Professor John Hopper (Centre for Genetic Epidemiology University of
Melbourne)
 GRA is based at the Prince of Wales Medical Research Institute in Sydney.
 Facility Manager is Mr Steve Turner.
GRA - Aims and Objectives

GRA aims to provide a central national facility for –
• establishing
• distributing and
• maintaining the long-term secure storage of human genetic
samples from a variety of sources.

GRA aims to facilitate world-class collaborative health and medical
research in Australia, and internationally through:
 the provision of clinically validated but de-identified patient
material
complete phenotypic descriptors of disease and family, or cohort
structure
permits genetic analyses for disease gene identification.
GRA - Services

A central facility for the processing of blood samples and production
of B-lymphoblastoid cell lines.

Extraction of DNA from blood or cell lines.

Samples will be processed from patients, controls and
epidemiological participants from studies on a range of diseases and
their outcomes.

DNA and immortalized cell lines will be stored for distribution to
qualified investigators.

Samples available for distribution will be processed at a subsidised
academic rate.

Fee-for-service work can be performed for samples not available for
distribution.
GRA
FURTHER INFORMATION
Mr Steve Turner, Facility Manager (GRA)
Prince of Wales Medical Research Institute
Randwick, Sydney,
Email: [email protected]
Telephone: (+ 61 2) 9399 1068
Website: www.powmri.edu.au/gra.htm
The ARCBS Aussie Normals

1000 ARCBS blood donors – healthy Caucasians

Cell lines & DNA

DNA available in 96 well plates from mid April
2007

Biochemical phenotype available via
collaboration with researchers (Cavanaugh &
Hickman @ ANU)

Projects subject to approval by ARCBS
AGRF Services

SNP Discovery

Genotyping

Expression analysis